Inner Retinal Dysfunction of the Cone System in Inherited Photoreceptor Degenerations: A Study of Disease Sequence and Assessment of Novel Therapeutic Strategies. - ND
- Conditions
- retinitis pigmentosaMedDRA version: 9.1Level: LLTClassification code 10038914Term: Retinitis pigmentosaMedDRA version: 9.1Level: PTClassification code 10038914Term: Retinitis pigmentosa
- Registration Number
- EUCTR2008-004561-26-IT
- Lead Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
1. diagnosi di RP tipica con pattern di disfunzione retinica tipo ?rod-cone?, determinata da esami elettroretinografici con cupola Ganzfeld e dalla perimetria con adattamento al buio, e dal classico aspetto del fondo oculare, 2. funzione centrale retinica parzialmente conservata (campo visivo valutato con mira V/4e > 30, acuita` visiva secondo ETDRS corretta > 20/40), 3. genotipo conosciuto o in valutazione, 4. almeno quattro valutazioni cliniche di follow-up nei precedenti tre anni, 5. assenza di opacita` dei mezzi diottrici, 6. assenza di patologie oculari concomitanti (e.g. glaucoma, ambliopia) o di patologie sistemiche
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
1. Typical RP with a rod-cone pattern of retinal dysfunction, as determined by standard Ganzfeld electroretinography and dark-adapted fundus perimetry, and classic fundus appearance, 2. Relatively preserved central retinal function (visual field by Goldmann V/4e > 30, corrected ETDRS visual acuity > 20/40), 3. Known genotype or genotype under study, 4. At least four follow-up clinical examination over the past three years, 5. No or minimal ocular media opacities, 6. No concomitant ocular (e.g. glaucoma, amblyopia) or systemic diseases
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method